Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHDgenotyping and a review of policy and practice
Open Access
- 25 February 2014
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 14 (1) , 87
Abstract
Since its introduction in the 1960s Anti-D immunoglobulin (Anti-D Ig) has been highly successful in reducing the incidence of haemolytic disease of the fetus and newborn (HDFN) and achieving improvements to maternal and fetal health. It has protected women from other invasive interventions during pregnancy and prevented deaths and damage amongst newborns and is a technology which has been adopted worldwide. Currently about one third of pregnant women with the blood group Rhesus D (RhD) negative in the UK (approximately 40,000 women per year in England and Wales), receive antenatal Anti-D Ig in pregnancy when they do not require it because they are carrying a RhD negative fetus. Since 1997, a test using cell free fetal DNA (cffDNA) in maternal blood has been developed to identify the genotype of the fetus and can be used to predict the fetal RhD blood group.Keywords
This publication has 15 references indexed in Scilit:
- Risky Bodies in the Plasma BioeconomyBody & Society, 2014
- A nation‐wide fetal RHD screening programme for targeted antenatal and postnatal anti‐DISBT Science Series, 2012
- Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxisTransfusion, 2011
- A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and WalesBMC Pregnancy and Childbirth, 2011
- Implementation of NICE recommendation for a policy of routine antenatal anti‐D prophylaxis: a survey of UK maternity unitsTransfusion Medicine, 2008
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- RHD Genotyping from Maternal Plasma: Guidelines and Technical Challenges2008
- Non-invasive antenatal RHD typingTransfusion Clinique et Biologique, 2006
- Prenatal typing of Rh and kell blood group system antigens: The edge of a watershedTransfusion Medicine Reviews, 2003
- Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in GermanyJournal of Hepatology, 1996